News
How does Marburg virus spread between species? Young Ugandan scientist’s photos give important clues
A 25-year-old local scientist captured rare footage showing how one of the world’s deadliest viruses could jump from bats to ...
2d
Health and Me on MSNThe Marburg Virus Is Back In Focus Thanks To A Ugandan Scientist, Here's What We Know So FarA Ugandan scientist's trail camera footage has revealed new insights into how the deadly Marburg virus may spread through bat ...
How does Marburg virus spread between species? Young Ugandan scientist's photos give important clues by Alexander Richard Braczkowski, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin ...
Conclusion Marburg virus disease remains a significant global health threat due to its high fatality rate, zoonotic origin, and potential for human-to-human transmission.
For past Marburg outbreaks in Uganda , two spillover pathways have been identified: the first, involves humans coming into contact with a fruit bat habitat (namely caves filled with bat guano).
Marburg virus articles from across Nature Portfolio Marburg virus is an infectious agent belonging to the virus family Filoviridae, which also includes the Ebolavirus genus, and causes a rare and ...
3d
Health and Me on MSNA Ugandan Scientist's Photos Reveal How Marburg Virus Can Spread To Different SpeciesMarburg virus is one of the world’s deadliest pathogens. Closely related to Ebola, it causes hemorrhagic fever with mortality ...
Some stood just metres from a known Marburg virus reservoir. Importantly, the Uganda Wildlife Authority has built a sanctioned viewing platform about 35 metres from the cave.
While the Marburg virus does not need an intermediate host en route to infecting humans, other novel viruses could follow such a path of first passing from bat to predator where it mutates into a ...
The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...
Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir. | Gilead has blamed the low rate of respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results